VitaSpring Biomedical Co. Ltd.
VSBC
$1.00
$0.000.00%
OTC PK
| 04/30/2023 | 10/31/2022 | 07/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 1.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 1.49M |
| Cost of Revenue | -- | -- | -- | -- | 922.00K |
| Gross Profit | -- | -- | -- | -- | 568.00K |
| SG&A Expenses | 304.60K | 182.90K | 170.50K | 170.50K | 224.90K |
| Depreciation & Amortization | -- | -- | 3.80K | 3.80K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 304.60K | 182.90K | 174.30K | 174.30K | 1.15M |
| Operating Income | -304.60K | -182.90K | -174.30K | -174.30K | 343.10K |
| Income Before Tax | -304.60K | -183.60K | -174.50K | -174.50K | 351.60K |
| Income Tax Expenses | -- | -45.60K | -30.30K | -30.30K | 75.00K |
| Earnings from Continuing Operations | -304.60K | -138.00K | -144.10K | -144.10K | 276.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -304.60K | -138.00K | -144.10K | -144.10K | 276.70K |
| EBIT | -304.60K | -182.90K | -174.30K | -174.30K | 343.10K |
| EBITDA | -300.80K | -179.20K | -170.50K | -170.50K | 346.90K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 207.03M | 206.52M | 206.52M | 206.52M | 206.52M |
| Average Diluted Shares Outstanding | 207.03M | 206.52M | 206.52M | 206.52M | 206.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |